The Immune Checkpoint Inhibitors Unleashed to Fight Cancer
• By Dana Direnzo, MD, Ami A. Shah, MD, MHS, Clifton O. Bingham III, MD, & Laura C. Cappelli, MD, MHS
- Connect with us:
ACR/ARP Meeting Abstracts
Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
ACR/ARP Annual Meeting
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
I would love to see more active treatments into Immunodeficiency illnesses like MS. If only the door would open for Stem cell treatment be made more available and not so red tapped… many more people could benefit…